Cohance Lifesciences Limited
Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process research & development to late-stage clinical and commercial manufacturing we are committed to provide customers with products fulfilling customer needs and expectations.
What Cohance files
- Investor Meet53
- Others52
- Updates27
- Important20
- PPTs7
- Board Meeting7
Cohance Lifesciences promoters, Jusmiral Holdings & Berhyanda Limited, have pledged a major chunk of their shares. They've encumbered 207,974,582 equity shares (54.36% of total company shares) to secure a new USD 28.5 Cr loan. This move is to refinance existing debt. Specifically: * **Jusmiral Holdings:** Pledged 80,434,990 shares (21.02% of...
Cohance Lifesciences' promoter Jusmiral Holdings Limited has sold 3.41 Cr equity shares, reducing its stake from 33.08% to 24.15%. This transaction 'releases' previous restrictions (covenants) on these shares. Proceeds from the sale will mainly be used to partly repay existing borrowings. It's important for investors to note that Jusmiral Holdings...